Healthcare leaders at this year’s HIMSS event advocated a measured, risk-aware approach to artificial intelligence deployment in clinical settings, emphasizing patient safety, regulatory compliance and clinical workflow alignment. Attendees said organizations are favoring controlled pilots and phased rollouts supported by governance frameworks that prioritize data quality, privacy, clinician oversight and interoperability. Health systems are also scrutinizing vendor claims, seeking evidence of clinical validation and operational impact before broader implementation.
Speakers and panelists stressed operational readiness—robust model validation, continuous performance monitoring, incident reporting, explainability and bias mitigation—as prerequisites for wider adoption. Workforce training, change management and clear liability frameworks were highlighted as essential to maintain clinician trust and patient safety. Leaders foresee incremental AI use targeted at augmenting diagnostics, administrative automation and decision support rather than wholesale clinician replacement, with multi-stakeholder collaboration and policy development guiding safe, sustainable scaling.
